BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21866062)

  • 1. Clinical neuroproteomics and biomarkers: from basic research to clinical decision making.
    Shoemaker LD; Achrol AS; Sethu P; Steinberg GK; Chang SD
    Neurosurgery; 2012 Mar; 70(3):518-25. PubMed ID: 21866062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translation of neurological biomarkers to clinically relevant platforms.
    Hayes RL; Robinson G; Muller U; Wang KK
    Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and development of biomarkers of neurological disease.
    Dunckley T; Coon KD; Stephan DA
    Drug Discov Today; 2005 Mar; 10(5):326-34. PubMed ID: 15749281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of current applications of mass spectrometry for neuroproteomics in epilepsy.
    Liu X; Wen F; Yang J; Chen L; Wei YQ
    Mass Spectrom Rev; 2010; 29(2):197-246. PubMed ID: 19598206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation.
    Kobeissy FH; Sadasivan S; Oli MW; Robinson G; Larner SF; Zhang Z; Hayes RL; Wang KK
    Proteomics Clin Appl; 2008 Oct; 2(10-11):1467-83. PubMed ID: 21136795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging biomarker platforms and systems biology for rehabilomics and biologics effectiveness research.
    Kobeissy FH; Guingab-Cagmat JD; Razafsha M; O'Steen L; Zhang Z; Hayes RL; Chiu WT; Wang KK
    PM R; 2011 Jun; 3(6 Suppl 1):S139-47. PubMed ID: 21703572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary proteomics in biomedical research.
    Zhang A; Sun H; Wang P; Wang X
    Clin Chim Acta; 2013 Jan; 415():261-5. PubMed ID: 23146870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroproteomics: understanding the molecular organization and complexity of the brain.
    Bayés A; Grant SG
    Nat Rev Neurosci; 2009 Sep; 10(9):635-46. PubMed ID: 19693028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics methods and applications for the practicing clinician.
    Reisdorph NA; Reisdorph R; Bowler R; Broccardo C
    Ann Allergy Asthma Immunol; 2009 Jun; 102(6):523-9. PubMed ID: 19558013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics technologies for biomarker discovery in multiple sclerosis.
    Singh V; Hintzen RQ; Luider TM; Stoop MP
    J Neuroimmunol; 2012 Jul; 248(1-2):40-7. PubMed ID: 22129845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical proteomics in neurodegenerative disorders.
    Zetterberg H; Rüetschi U; Portelius E; Brinkmalm G; Andreasson U; Blennow K; Brinkmalm A
    Acta Neurol Scand; 2008 Jul; 118(1):1-11. PubMed ID: 18279484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of urinary proteomics/peptidomics.
    Albalat A; Mischak H; Mullen W
    Expert Rev Proteomics; 2011 Oct; 8(5):615-29. PubMed ID: 21999832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traumatic brain injury biomarkers: from pipeline to diagnostic assay development.
    Oli MW; Hayes RL; Robinson G; Wang KK
    Methods Mol Biol; 2009; 566():293-302. PubMed ID: 20058179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker identification in neurologic diseases: improving diagnostics and therapeutics.
    Coon KD; Dunckley T; Stephan DA
    Expert Rev Mol Diagn; 2004 May; 4(3):361-75. PubMed ID: 15137903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.
    Issaq HJ; Waybright TJ; Veenstra TD
    Electrophoresis; 2011 Apr; 32(9):967-75. PubMed ID: 21449066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The methodology of neuroproteomics.
    Ottens AK
    Methods Mol Biol; 2009; 566():1-21. PubMed ID: 20058161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.